The World Market for Pain Management Drugs and Devices: Applications and Top Products
The market for pain management products is growing at a brisk pace, with some segments moving ahead at over 20%. The future for specialized pharmaceutical and medical device products in this market is bright and new opportunities exist for emerging treatment modalities as well.
The report presents information about the top-producing pain management products in terms of revenues, and analyzes the market by specific pain sites as well. The report concentrates on the following application areas:
- Burn Pain
- Cancer Pain
- Dental/Facial Pain
- Headache Pain
- MusculoSkeletal Pain
- Neuropathic Pain
- Pediatric Pain
- Surgical and Trauma Pain
- Other Pain
Market sizes are provided in U.S. dollars for the years 2003-2008 at the manufacturer’s level. Competitive market share of the top players is discussed in each application area, and individual product revenue breakdowns are provided for top products.
In addition to drugs, medical device markets and alternate pain management modalities are also included in the analysis. Medical devices included in the analysis include:
- Transcutaneous Electrical Nerve Stimulators
- Neuromuscular Stimulators
- Spinal Cord Stimulators
- PCA and Supplies
- Electrothermal and Electromagnetic Therapy
Markets are discussed on two geographic levels. The focus of the analysis is global, but a break out of the U.S. market is provided as well. Trends in clinical practice, guidelines and protocols, reimbursement, regulatory affairs, and the competitive marketplace are also discussed.
Table of Contents
Chapter One: Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
Issues and Trends
Leading Competitors
Chapter Two: Introduction and Overview
Definition of Pain
Magnitude of Pain
Physiology of Pain
Transduction
Transmission
Pain Pathways
Types of Pain
Measurement of Pain
Treatment Modalities—Pharmacologic Management
Analgesic Ladder
Recommended Drug and Route
Treatment Modalities—
Non-pharmacologic Management
Cognitive-Behavioral Therapies
Multidisciplinary Pain Management
Demographics
Chapter Three: Treatment Markets and Forecasts
Burn Pain
Overview of Top Products
Market Size and Growth
The U.S. Market
Non-U.S. Market
Cancer Pain
Breakthrough Cancer Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Dental/Facial Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Migraine Headache Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Musculoskeletal Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Neuropathic Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Obstetrical Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Pediatric Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Surgical and Trauma Pain
Overview of Top Products
Market Size and Growth
U.S. Market
Non-U.S. Market
Chapter Four: Drug Delivery
Oral Drug Delivery
Parenteral Drug Delivery
Transdermal
Patient Controlled Analgesia
Intrathecal Implants
Electrotransport Drug Delivery
Drug Delivery in Development
Chapter Five: Pain Management Devices
Transcutaneous Electrical Nerve Stimulators
Neuromuscular Stimulators
Spinal Cord Stimulators and Peripheral Nerve Stimulators
PCAs and Intrathecal Pain Pumps
Other Miscellaneous devices
Cranial electrotherapy stimulation
Electrothermal and Electromagnetic Therapy
Market Size and Growth
U.S. Market
Non-U.S. Market
Chapter Six: Alternate Treatment Modalities
Acupuncture
ETPS Neuropathic Acupuncture
Low Level Laser Light Therapy
Biofeedback
Relaxation
Acupressure
Massage Therapy
Natural Supplements in Pain Management
Chapter Seven: Issues and Trends
Overview
Regulatory issues
National Pain Care Policy Act of 2003
Barriers to Cancer Pain Management
Education
Managed Care Pain Management
The Fifth Vital Sign
Use of Psychopharmacology in Chronic Pain
Vioxx Recall
Increasing use of Botulinum Neurotoxin
Research and Development
The Elderly
Oxycontin Issues
Chapter Eight: Market Summary
Total Market Size and Forecast
Top Revenue-Producing Products
Competitive Analysis
Chapter Nine: Corporate Profiles
AAI Pharma Inc.
Abbott Laboratories
AstraZeneca plc.
Baxter International, Inc
Bristol-Myers Squibb Company
Cephalon Inc.
Compex Technologies
Empi, Inc
Encore Medical corporation
Endo Pharmaceutical Holdings Inc
GlaxoSmithKline plc
Johnson & Johnson, Inc.
Labopharm Inc.
Meditech International, Inc.
Medtronic, Inc.
Merck & Company
Novartis
Ortho-McNeil
Pfizer, Inc.
Purdue Pharma
Sanofi-Synthelabo (Sanofi-Aventis)
TEVA Pharmaceutical Industries, Ltd.
Watson Pharmaceuticals, Inc.
Wyeth
APPENDIX a: Company Directory
Appendix B: Selected Pain Management Organizations
List of Exhibits
Chapter One: Executive Summary
Table 1-1: World Pain Management Market 2003-2009
Table 1-2: World Pain Management Market by Product Segment
(Pain Type), 2003-2009
Chapter Two: Introduction and Overview
Table 2-1: Most Commonly Used Pain Quality Descriptors
Table 2-2: Pharmacokinetics of Step I Analgesics by Product
Table 2-3: Step II Analgesics: Pharmacokinetics
Table 2-4: Step III Analgesics: Pharmacokinetics
Table 2-5: Prevalence of Selected Pain-Related Conditions
Chapter three: Treatment Markets and Forecasts
Table 3-1: World Market for Burn Pain Market 2003-2009
Figure 3-1: World Market for Burn Pain Management 2003-2009
Table 3-2: U.S. Market for Burn Pain Management 2003-2009
Figure 3-2: U.S. Market for Burn Pain Management 2003-200
Table 3-3: Non-U.S. Market for Burn Pain Management 2003-2009
Figure 3-3: Non-U.S. Market for Burn Pain Management 2003-2009
Table 3-4: World Market for Cancer Pain Management 2003-2009
Figure 3-4: World Market for Cancer Pain Management 2003-2009
Table 3-5: The U.S. Market for Cancer Pain Management 2003-2009
Figure 3-5: The U.S. Market for Cancer Pain Management 2003-2009
Table 3-6: The Non-U.S. Market for Cancer Pain Management 2003-2009
Figure 3-6: The Non-U.S. Market for Cancer Pain Management 2003-2009
Table 3-7: The World Market for Dental/Facial Pain Management 2003-2009
Figure 3-7: The World Market for Dental/Facial Pain Management 2003-2009
Table 3-8: The U.S. Market for Dental/Facial Pain Management 2003-2009
Figure 3-8: The U.S. Market for Dental/Facial Pain Management 2003-2009
Table 3-9: The Non-U.S. Market for Dental/Facial Pain
Management 2003-2009
Figure 3-9: The Non-U.S. Market for Dental/Facial Pain
Management 2003-2009
Table 3-10: World Market for Migraine Pain Management 2003-2009
Figure 3-10: World Market for Migraine Pain Management 2003-2009
Table 3-11: The U.S. Market for Migraine Pain Management 2003-2009
Figure 3-11: The U.S. Market for Migraine Pain Management 2003-2009
Table 3-12: The Non-U.S. Market for Migraine Pain Management 2003-2009
Figure 3-12: The Non-U.S. Market for Migraine Pain Management 2003-2009
Table 3-13: World Market for Musculoskeletal Pain Management 2003-2009
Figure 3-13: World Market for Musculoskeletal Pain Management 2003-2009
Table 3-14: The U.S. Market for Musculoskeletal Pain Management 2003-2009
Figure 3-14: The U.S. Market for Musculoskeletal Pain Management 2003-2009
Table 3-15: The Non-U.S. Market for Musculoskeletal Pain
Management 2003-2009
Figure 3-15: The Non-U.S. Market for Musculoskeletal Pain
Management 2003-2009
Table 3-16: World Market for Neuropathic Pain Management 2003-2009
Figure 3-16: World Market for Neuropathic Pain Management 2003-2009
Table 3-17: The U.S. Market for Neuropathic Pain Management 2003-2009
Figure 3-17: The U.S. Market for Neuropathic Pain Management 2003-2009
Table 3-18: The Non-U.S. Market for Neuropathic Pain
Management 2003-2009
Figure 3-18: The Non-U.S. Market for Neuropathic Pain
Management 2003-2009
Table 3-19: World Market for Obstetrical Pain Management 2003-2009
Figure 3-19: World Market for Obstetrical Pain Management 2003-2009
Table 3-20: The U.S. Market for Obstetrical Pain Management 2003-2009
Figure 3-20: The U.S. Market for Obstetrical Pain Management 2003-2009
Table 3-21: The Non-U.S. Market for Obstetrical Pain Management 2003-2009
Figure 3-21: The Non-U.S. Market for Obstetrical Pain Management 2003-2009
Table 3-22: The World Market for Pediatric Pain Management 2003-2009
Figure 3-22: Total World Pediatric Pain Market 2003-2009
Table 3-23: The U.S. Market for Pediatric Pain Management 2003-2009
Table 3-23: The U.S. Market for Pediatric Pain Management 2003-2009
Table 3-24: The Non-U.S. Market for Pediatric Pain Management 2003-2009
Figure 3-24: The Non-U.S. Market for Pediatric Pain Management 2003-2009
Table 3-25: World Market for Surgical and Trauma Pain
Management 2003-2009
Figure 3-25: World Market for Surgical and Trauma Pain
Management 2003-2009
Table 3-26: The U.S. Market for Surgical and Trauma Pain
Management 2003-2009
Figure 3-26: The U.S. Market for Surgical and Trauma Pain
Management 2003-2009
Table 3-27: The Non-U.S. Market for Surgical and Trauma Pain
Management 2003-2009
Figure 3-27: The Non-U.S. Market for Surgical and Trauma Pain
Management 2003-2009
Chapter Five: Pain Management Devices
Table 5-1: World Market for Pain Management Devices 2003-2009
Figure 5-1: World Market for Pain Management Devices 2003-2009
Table 5-2: U.S. Market for Pain Management Devices 2003-2009
Figure 5-2: U.S. Market for Pain Management Devices 2003-2009
Table 5-3: The Non-U.S. Market for Pain Management Devices 2003-2009
Figure 5-3: The Non-U.S. Market for Pain Management Devices 2003-2009
Chapter Six: Alternate Treatment Modalities
Table 6-1: Pain Management Supplements in Clinical Trials
Chapter Seven: Issues and Trends
Table 7-1: Pain Management Products in Development 2004
Chapter Eight: Market Summary
Table 8-1: World Pain Management Market 2003-2009
Table 8-2: World Pain Management Market by Product Segment (Pain Type + Devices) 2003-2009
Figure 8-1: World Pain Management Market by Product Segment 2003-2009
Figure 8-2: World Market Pain Management Market Share by Product Segment 2004
Figure 8-3: The World Market Pain Management Projected Market Share by Product Segment 2009
Table 8-3: Revenues and Market Share by Top Revenue Producing Products 2004. 174
Figure 8-4: Market Share by Top Revenue Producing Products 2004
Table 8-4: World Market for Top Pain Management Drugs Revenues and Major Segments of Participation by Competitor 2004
Other users found this report page using the following search terms: pain devices pain market management size devices drugs world neuropathic us cancer
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.